title: Toxicological assays for testing effects of an epigenetic drug on development, fecundity and survivorship of malaria mosquitoes.
abstract: Insecticidal resistance poses a major problem for malaria control programs. Mosquitoes adapt to a wide range of changes in the environment quickly, making malaria control an omnipresent problem in tropical countries. The emergence of insecticide resistant populations warrants the exploration of novel drug target pathways and compounds for vector mosquito control. Epigenetic drugs are well established in cancer research, however not much is known about their effects on insects. This study provides a simple protocol for examining the toxicological effects of 3-Deazaneplanocin A (DZNep), an experimental epigenetic drug for cancer therapy, on the malaria vector, Anopheles gambiae. A concentration-dependent increase in mortality and decrease in size was observed in immature mosquitoes exposed to DZNep, whereas the compound reduced the fecundity of adult mosquitoes relative to control treatments. In addition, there was a drug-dependent decrease in S-adenosylhomocysteine (SAH) hydrolase activity in mosquitoes following exposure to DZNep relative to control treatments. These protocols provide the researcher with a simple, step-by-step procedure to assess multiple toxicological endpoints for an experimental drug and, in turn, demonstrate a unique multi-prong approach for exploring the toxicological effects of water-soluble epigenetic drugs or compounds of interest against vector mosquitoes and other insects.
authors: Department of Entomology, Virginia Tech.
authors: Atashi
authors: A
authors: Sharma
authors: Department of Entomology, Virginia Tech.
authors: Troy D
authors: TD
authors: Anderson
authors: Department of Entomology, Virginia Tech; igor@vt.edu.
authors: Igor V
authors: IV
authors: Sharakhov
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D043383:Adenosylhomocysteinase / Q000037:antagonists & inhibitors; D000818:Animals; D000852:Anopheles / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000469:parasitology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005298:Fertility / Q000187:drug effects; D007303:Insect Vectors / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D007305:Insecticide Resistance; D007306:Insecticides / Q000494:pharmacology*; D008288:Malaria / Q000469:parasitology / Q000635:transmission; D008297:Male; D009032:Mosquito Control / Q000379:methods*; D012435:S-Adenosylhomocysteine; D015996:Survival Rate
chemical_list: D007306:Insecticides; C048460:3-deazaneplanocin; D012435:S-Adenosylhomocysteine; D043383:Adenosylhomocysteinase; D000241:Adenosine
references: Evolution. 2013 Apr;67(4):1218-30
references: 23550770
references: Oncol Rep. 2014 Feb;31(2):983-8
references: 24337160
references: Trans R Soc Trop Med Hyg. 1979;73(5):483-97
references: 394408
references: Oncotarget. 2013 Dec;4(12 ):2532-49
references: 24345883
references: Mol Cancer. 2011 Apr 18;10:40
references: 21501485
references: J Biol Chem. 2014 Mar 21;289(12 ):8121-34
references: 24492606
references: Nat Rev Genet. 2012 Apr 03;13(5):343-57
references: 22473383
references: Cell. 2007 Feb 23;128(4):693-705
references: 17320507
references: Trends Parasitol. 2014 Mar;30(3):115-22
references: 24513566
references: Nat Rev Genet. 2012 Jan 18;13(2):123-34
references: 22251873
references: Int J Mol Sci. 2013 Dec 12;14 (12 ):24154-68
references: 24351808
references: Malar J. 2009 Jul 02;8:147
references: 19573238
references: Genes Dev. 2007 May 1;21(9):1050-63
references: 17437993
references: J Biol Chem. 2013 Aug 9;288(32):23554-64
references: 23814061
references: Dev Biol. 2014 Apr 15;388(2):181-91
references: 24485852
references: Biochem Pharmacol. 1979 Jun 15;28(12):1897-902
references: 454462
references: J Clin Endocrinol Metab. 2014 Jun;99(6):E962-70
references: 24512488
references: Cell. 2012 Jul 6;150(1):12-27
references: 22770212
references: Mol Cancer Ther. 2009 Jun;8(6):1579-88
references: 19509260